Doximity outlines FY 2027 revenue of $678M-$683M as AI search reaches 8-figure bookings
What it means
- What to watch: Drugmakers live and die by pipelines — what is in late-stage trials matters more than this quarter's sales.
- How the stock is trading: $DOCS -2.02% in the latest session.
- Timing: Filed after the close: the price beside it finished its day before the story existed, so the next session gets the first real vote.
Where the stock stands
$DOCS last changed hands at $32.51, -2.02% on the session, 44% below its 52-week high of $58.24 and 90% above its low of $17.15 — a little below the middle of the range. Over the year it has ranged 240% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $DOCS page.
How much coverage it is getting
Wook has logged 3 stories on $DOCS in the last 30 days, 3 of them this week. At its 30-day pace you would expect about 1 a week, so this week is running well ahead of normal; the press has found a reason to keep writing. Across those stories 1 read bullish, 2 neutral and 0 bearish. This one reads neutral, so it sits in step with most of the run. 3 of the 3 (100%) came from Seeking Alpha itself, so the count says as much about how often Seeking Alpha hits publish as about how much attention there is — the other outlets are the better gauge. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
What to watch next
For the receipts, the $DOCS page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and run the numbers on request — how far $DOCS is from its high, or how this week's coverage compares.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $DOCS. It carried $678 million and $683 million, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.